Table 5.
Total (n=2458) |
Female (n=1931) |
Male (n=527) |
Unadjusted RR (95% CI) |
Adjusted RRa (95% CI) |
|
---|---|---|---|---|---|
Comorbidity | |||||
Hypertensionb | 1596(67.2) | 1187(63.9) | 409(79.3) | 1.23(1.17, 1.30)c | 1.18(1.11, 1.26)c |
Dyslipidemiad | 1242(63.4) | 885(57.9) | 357(83.0) | 1.37 (1.30, 1.44)c | 1.34 (1.26, 1.41)c |
Sleep apneae | 1288(52.5) | 904(46.9) | 384(73.0) | 1.56(1.45, 1.67)c | 1.47(1.35, 1.60)c |
Urinary incontinencef | 962(42.9) | 862(48.9) | 100(21.0) | 0.43(0.36, 0.51)c | 0.32(0.25, 0.41)c |
Hyperlipidemiag | 719(36.6) | 507(33.1) | 212(49.0) | 1.40(1.26, 1.56)c | 1.20(1.10, 1.31)c |
Diabetesh | 773(33.4) | 546(30.0) | 227(45.9) | 1.51(1.34, 1.69)c | 1.41(1.26, 1.57)c |
Asthmai | 607(25.3) | 511(27.2) | 96(18.6) | 0.68(0.56, 0.83)c | 0.68(0.56, 0.83)c |
Abnormal kidney functionj | 199(8.5) | 137(7.5) | 62(12.4) | 1.66(1.25, 2.20)c | 1.27(0.97, 1.66) |
Venous edemad | 172(7.0) | 106(5.5) | 66(12.6) | 2.28(1.71, 3.06)c | 1.83(1.40, 2.39)c |
Severe walking limitationk | 153(6.8) | 120(6.9) | 33(6.8) | 0.99(0.68, 1.44) | 0.75(0.53, 1.06) |
Ischemic heart diseasel | 151(6.3) | 82(4.4) | 69(13.3) | 2.99(2.21, 4.05)c | 2.44(1.81, 3.29)c |
Congestive heart failuree | 48(2.0) | 21(1.1) | 27(5.1) | 4.72(2.69, 8.27)c | 6.18(3.09, 12.37)c |
Pulmonary e, m | 28(1.1) | 22(1.1) | 6(1.1) | 1.00(0.41, 2.46) | - |
Data presented as number of participants, with percentages in parentheses, unless otherwise indicated.
Relative risks presented at median age (46 years) and body mass index (45.9 kg/m2) after adjusting for age, body mass index, and significant interactions.
86 missing from prevalence estimate; 50 missing from models
p<.05.
499 missing from prevalence estimate; 253 missing from models
3 missing
218 missing
491 missing from prevalence estimate; 341 missing from models
145 missing from prevalence estimate; 54 missing from models
62 missing
117 missing
221 missing
58 missing from prevalence estimate; 56 missing from models
Too rare to adjust for covariates.